Tetsuro Oishi

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma

Hiroaki Itamochi, Tetsuro Oishi, Nao Oumi et al. · British Journal of Cancer · 2017 · 110 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross et al. · Annals of Oncology · 2016 · 106 citations · Full text

Veterinary Medicine, Oncology, Pathology +14

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Combination chemotherapy of oxaliplatin and 5‐fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy

Seiya Sato, Hiroaki Itamochi, Junzo Kigawa et al. · Cancer Science · 2008 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer

Hiroaki Komatsu, Tetsuro Oishi, Hiroaki Itamochi et al. · International Journal of Gynecological Cancer · 2017 · 80 citations

Medicine, Oncology, Pathology +16